There is huge demand for customizable raw materials says newly-named Actylis, as it targets further M&A to propel itself into the bioprocess space. In 2019, raw material and ingredient distributor Aceto was acquired by private equity (PE) firm New Mountain Capital. Since then, the firm has moved away from being a virtual supplier via an M&A strategy that has seen seven acquisitions within a two-year period. The acquisitions were: intermediate developers and makers Syntor and IsleChem, large molecule input firm…

Drug makers need data standards to realize the full benefits of digital manufacturing tech, according to new analysis. The research – by German technology conglomerate Siemens – focused on how digital systems are reshaping the production of medicines with the authors quizzing executives from 31 firms in the UK and Ireland about changes over the past two years. And the key finding is that biopharmaceutical firms need data standards according to the authors, who cite integration as a major challenge…